Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

OBJECTIVE Choices of pharmacologic therapies for pulmonary arterial hypertension (PAH)
are ideally guided by high-level evidence. The objective of this guideline is to provide …

Guidelines summarize and evaluate available evidence, with the aim of assisting health
professionals in proposing the best management strategies for an individual patient with a …

BTS recommendations for managing passengers with stable respiratory disease planning
air travel were published in Thorax in 2011. 1 This followed original guidance published in …

In the summer of 2016, delegates from the German Respiratory Society, the German Society
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …

Background There is insufficient evidence to counsel patients with pulmonary hypertension
undergoing altitude or air travel. We thus aimed to study hemodynamic response of patients …

In recent times many people stay temporarily at high altitudes. It is mainly associated with
the growing popularity of regular air travel, as well as temporary trips to mountain regions …

The number of children on commercial aircrafts is rising steeply and poses a need for their
treating physicians to be aware of the physiologic effects and risks of air travel. The most …

Objective Patients with pulmonary arterial hypertension (PAH) are often recommended
supplemental oxygen for altitude travel due to the possible deleterious effects of hypoxia on …

As the population ages and our ability to care for patients with cardiac disease improves, an
increasing number of passengers with cardiovascular conditions will be traveling long …